Chengli Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chengli Zhang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Chao Yu
Chongqing Medical University
7 shared publications Jun Chen
Institute of Life Science, College of Pharmacy and School of Public Health, Chongqing Medical University, Chongqing, 400016, PR China
5 shared publicationsJunlin He
Institute of Life Science, College of Pharmacy and School of Public Health, Chongqing Medical University, Chongqing, 400016, PR China
5 shared publicationsJia Li
4 shared publicationsMinggang Yin
3 shared publicationsWeiran Mao
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 12 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (50) , eady3070
DNA-directed electrochemiluminescence nanosphere with electrocatalysis-enhanced microfluidic arrays for rapid multibacterial detection
Rapid detection of multibacterial pathogens is crucial for accelerating the diagnosis and treatment of bacterial infections. We propose a rapid and efficient electrochemiluminescence (ECL) sensor for the synchronous detection of multiple bacterial pathogens, including Staphylococcus aureus , Klebsiella pneumoniae , Pseudomonas aeruginosa , and methicillin-resistant S. aureus . This homogeneous sensor is based on a self-assembled DNA nanosphere loaded with tetrakis (4-carboxyphenyl) porphyrin (TCPP). The sensor operates in an “off-on” mode, in which bacterium-aptamer binding triggers a conformational change in the DNA nanosphere, releasing TCPP and generating an enhanced ECL signal. The inclusion of cerium nanoparticles boosts signal intensity through electrocatalytic reactions, improving sensitivity with a detection limit of ≤100 colony-forming units per milliliter. Integrated with a microfluidic chip, the system enables multibacterial detection in just 45 minutes. Bacterial quantification in clinical samples strongly correlates with digital polymerase chain reaction results. This approach provides a rapid, specific, and efficient diagnostic tool for bacterial infections with great potential for point-of-care applications in clinical settings.
- 12 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (50) , eady3070
Top Cited PapersOpen AccessDNA-directed electrochemiluminescence nanosphere with electrocatalysis-enhanced microfluidic arrays for rapid multibacterial detection
Rapid detection of multibacterial pathogens is crucial for accelerating the diagnosis and treatment of bacterial infections. We propose a rapid and efficient electrochemiluminescence (ECL) sensor for the synchronous detection of multiple bacterial pathogens, including Staphylococcus aureus , Klebsiella pneumoniae , Pseudomonas aeruginosa , and methicillin-resistant S. aureus . This homogeneous sensor is based on a self-assembled DNA nanosphere loaded with tetrakis (4-carboxyphenyl) porphyrin (TCPP). The sensor operates in an “off-on” mode, in which bacterium-aptamer binding triggers a conformational change in the DNA nanosphere, releasing TCPP and generating an enhanced ECL signal. The inclusion of cerium nanoparticles boosts signal intensity through electrocatalytic reactions, improving sensitivity with a detection limit of ≤100 colony-forming units per milliliter. Integrated with a microfluidic chip, the system enables multibacterial detection in just 45 minutes. Bacterial quantification in clinical samples strongly correlates with digital polymerase chain reaction results. This approach provides a rapid, specific, and efficient diagnostic tool for bacterial infections with great potential for point-of-care applications in clinical settings.
- Open Access
- 22 January 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (1) , e1158
Effect of serum inflammatory factors in predicting co‐infection with influenza viruses and Omicron
Objectives: To identify the key differences in laboratory indicators between mono‐infection and co‐infection by influenza viruses and Omicron to facilitate timely adjustments in patient treatment strategies.Methods: Prealbumin and C‐reactive protein (CRP) levels were analyzed in 161 COVID‐19 cases infected by SARS‐CoV‐2 (wild type), 299 cases infected by Omicron, 95 cases infected by influenza virus A/B (Flu A/B) and 133 co‐infection cases infected with Flu A/B and Omicron. The receiver operating characteristic (ROC) curve and logistic regression equation were used to analyze the clinical predictive capacity of prealbumin and CRP in coinfected patients.Results: The co‐infected and wild‐type infected patients had significantly different CRP and prealbumin levels compared to mono‐infected patients with Omicron or Flu A/B (p < .001). The ROC curve results indicated that prealbumin was more efficient than CRP in identifying co‐infection from Omicron (AUC: 0.867 vs. 0.724) or Flu A/B (AUC: 0.797 vs. 0.730), and joint prediction significantly improved the diagnostic ability to discriminate co‐infection from mono‐infection (AUC: 0.934 and 0.887).Conclusion: The findings suggest that prealbumin is a valuable indicator that can warn of co‐infection and guide timely treatment decisions. Joint prediction may offer an even more effective diagnostic tool for discriminating co‐infection from mono‐infection.
- 22 January 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (1) , e1158
Open AccessEffect of serum inflammatory factors in predicting co‐infection with influenza viruses and Omicron
Objectives: To identify the key differences in laboratory indicators between mono‐infection and co‐infection by influenza viruses and Omicron to facilitate timely adjustments in patient treatment strategies.Methods: Prealbumin and C‐reactive protein (CRP) levels were analyzed in 161 COVID‐19 cases infected by SARS‐CoV‐2 (wild type), 299 cases infected by Omicron, 95 cases infected by influenza virus A/B (Flu A/B) and 133 co‐infection cases infected with Flu A/B and Omicron. The receiver operating characteristic (ROC) curve and logistic regression equation were used to analyze the clinical predictive capacity of prealbumin and CRP in coinfected patients.Results: The co‐infected and wild‐type infected patients had significantly different CRP and prealbumin levels compared to mono‐infected patients with Omicron or Flu A/B (p < .001). The ROC curve results indicated that prealbumin was more efficient than CRP in identifying co‐infection from Omicron (AUC: 0.867 vs. 0.724) or Flu A/B (AUC: 0.797 vs. 0.730), and joint prediction significantly improved the diagnostic ability to discriminate co‐infection from mono‐infection (AUC: 0.934 and 0.887).Conclusion: The findings suggest that prealbumin is a valuable indicator that can warn of co‐infection and guide timely treatment decisions. Joint prediction may offer an even more effective diagnostic tool for discriminating co‐infection from mono‐infection.
- Open Access
- 7 March 2023
- Published by Wiley
Effect of serum inflammatory factors in predicting co-infection with influenza viruses and Omicron
A document by Chengli Zhang. Click on the document to view its contents.
- 7 March 2023
- Published by Wiley
Open AccessEffect of serum inflammatory factors in predicting co-infection with influenza viruses and Omicron
A document by Chengli Zhang. Click on the document to view its contents.
- 7 February 2020
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 58 (10) , e209-e211
Serum prealbumin deserves more significance in the early triage of COVID-19 patients
Article Serum prealbumin deserves more significance in the early triage of COVID-19 patients was published on October 1, 2020 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 58, issue 10).
- 7 February 2020
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 58 (10) , e209-e211
Serum prealbumin deserves more significance in the early triage of COVID-19 patients
Article Serum prealbumin deserves more significance in the early triage of COVID-19 patients was published on October 1, 2020 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 58, issue 10).
- 1 January 2020
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 66 (06/2020) , 1151-1154
Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin
- 1 January 2020
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 66 (06/2020) , 1151-1154
Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin
- 3 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (1) , 338-346
Novel Ce(III)-Metal Organic Framework with a Luminescent Property To Fabricate an Electrochemiluminescence Immunosensor
We designed a novel luminescent metal-organic framework (LMOF) named CTM through a simple one-pot solvothermal method. CTM was synthesized by using the emerging electrochemiluminescent (ECL) material (4,4′,4′′,4′′′-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid) as organic ligand and Ce(Ⅲ) as metal node. We found that CTM not only has the remarkable ability to emit light but also has a uniform “sandwich biscuit” shape and suitable nanoscale size, which are promising for further applications. We also applied CTM to construct a novel ECL immunosensor and achieve the sensitive detection of the proprotein convertase subtilisin/kexin type 9 (PCSK9), a biomarker related to cardiovascular diseases (CVDs). To further amplify the ECL signal of CTM, a novel dual-amplified signal strategy was established by inducing polyamidoamine dendrimer (PAMAM) and gold nanoparticle (AuNPs). Importantly, we firstly proved that the ECL signal of CTM/S2O82- system could be enhanced by PAMAM electric field. Since the electron transfer rate was accelerated by AuNPs layer, this ECL signal was further enhanced in AuNPs-modified electrodes. The ECL immunosensor showed desirable performance for PCSK9 analysis within a detection range of 50 fg mL-1 to 10 ng mL-1 and a low LOD of 19.12 ± 2.69 fg mL-1. Real sample detection suggested that the immunosensor holds great potential for clinical serum samples analyzing.
- 3 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (1) , 338-346
Novel Ce(III)-Metal Organic Framework with a Luminescent Property To Fabricate an Electrochemiluminescence Immunosensor
We designed a novel luminescent metal-organic framework (LMOF) named CTM through a simple one-pot solvothermal method. CTM was synthesized by using the emerging electrochemiluminescent (ECL) material (4,4′,4′′,4′′′-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid) as organic ligand and Ce(Ⅲ) as metal node. We found that CTM not only has the remarkable ability to emit light but also has a uniform “sandwich biscuit” shape and suitable nanoscale size, which are promising for further applications. We also applied CTM to construct a novel ECL immunosensor and achieve the sensitive detection of the proprotein convertase subtilisin/kexin type 9 (PCSK9), a biomarker related to cardiovascular diseases (CVDs). To further amplify the ECL signal of CTM, a novel dual-amplified signal strategy was established by inducing polyamidoamine dendrimer (PAMAM) and gold nanoparticle (AuNPs). Importantly, we firstly proved that the ECL signal of CTM/S2O82- system could be enhanced by PAMAM electric field. Since the electron transfer rate was accelerated by AuNPs layer, this ECL signal was further enhanced in AuNPs-modified electrodes. The ECL immunosensor showed desirable performance for PCSK9 analysis within a detection range of 50 fg mL-1 to 10 ng mL-1 and a low LOD of 19.12 ± 2.69 fg mL-1. Real sample detection suggested that the immunosensor holds great potential for clinical serum samples analyzing.
- 1 December 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 145, 111677
A trimetallic CuAuPd nanowire as a multifunctional nanocomposites applied to ultrasensitive electrochemical detection of Sema3E
- 1 December 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 145, 111677
A trimetallic CuAuPd nanowire as a multifunctional nanocomposites applied to ultrasensitive electrochemical detection of Sema3E
- 1 November 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 144, 111575
A novel light-electricity sensing method for PCSK9 detection based on s-PdNFs with multifunctional property
- 1 November 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 144, 111575
A novel light-electricity sensing method for PCSK9 detection based on s-PdNFs with multifunctional property
- 1 May 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 132, 302-309
Trimetallic signal amplification aptasensor for TSP-1 detection based on Ce-MOF@Au and AuPtRu nanocomposites
- 1 May 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 132, 302-309
Trimetallic signal amplification aptasensor for TSP-1 detection based on Ce-MOF@Au and AuPtRu nanocomposites